Strategy& Insider Episode 35 - Unraveling dementia and neurocognitive diseases

Join Nitya Dintakurti, the pioneering Founder and CEO of Unpause, as she transforms menopause support and women's health. In this episode, we explore the diverse challenges women face during this hormonal transition and how Unpause is reshaping the landscape with cutting-edge technology and innovation. Tune in for a captivating conversation on FemTech and the critical role of personalized and digitized approaches in advancing women's health outcomes.

This episode features Prof. Dr. Robert Perneczky who serves as Professor of Translational Dementia Research and Head of Geriatric Psychiatry at Ludwig-Maximilians University in Munich. Dive into the intricate realm of dementia and neurocognitive disorders as he reveals groundbreaking advancements in disease-modifying treatments and emphasizes the crucial role of lifestyle factors in mitigating dementia risk. Explore how cutting-edge innovations in biomarkers and interdisciplinary methodologies are revolutionizing the future of dementia care and gain insightful strategies to enhance resilience against neurodegeneration.

Dr. Eicke Latz is a leading immunologist, Director of the German Rheumatology Research Center and Professor of Experimental Rheumatology at Charité Hospital in Berlin. In this episode, he offers valuable insights into his research on the innate immune system's role in maintaining health and its potential to promote disease. He explores the molecular mechanisms that activate or inhibit the immune system, impacting inflammation in diseases such as rheumatic disorders, arteriosclerosis, and Alzheimer's. Join us for an enlightening discussion on precision immuno-diagnostics and AI-driven medicine, which promise a future where targeted therapies address the root causes of diseases.

In this episode, Dr. Hadi Saleh, CEO of CeramTec, delves into the intricacies of navigating a shifting MedTech market with the rise of weight-loss blockbuster drugs as well as the influence of macroeconomic and geopolitical tensions on healthcare product development and innovation. The discussion also explores preventive care, the significance of a healthy lifestyle, and the potential of genetic editing and personalized medicine. Tune in for an engaging and informative conversation.

In this episode, we welcome two trailblazers in the field of stem cell research: Join Prof. Dr. Katarina Le Blanc, a leading expert with over two decades of experience, as she shares her groundbreaking work with stem cells and how her research has contributed to the mission of making stem cell treatments and research more accessible through Cellcolabs. Accompanying her is Dr. Mattias Bernow, CEO of Cellcolabs, who brings a unique blend of medical and business expertise to the conversation, revealing strategies to make these revolutionary therapies affordable. Tune in to explore the transformative potential of stem cell research in disease care and prevention.

In this episode, we explore the forefront of rare disease research with Professor Matthew Wood, the Director and Chief Scientific Officer at the Oxford-Harrington Rare Disease Centre (OHC). Professor Wood shares his inspiring journey from his early studies in Cape Town to his impactful career at Oxford University. Learn about the innovative initiatives at OHC and their ambitious plan to bring 40 drugs into clinical trials within the next decade. This episode provides valuable insights into the challenges and opportunities in rare disease treatment, presenting a hopeful vision for rapid diagnosis and effective therapies.

Prof. Dr. Mandy Mangler stands out as a prominent voice for change in women's healthcare. As the Medical Director and Chief Physician at two leading Berlin clinics, she champions the empowerment of women by stressing the critical need for evidence-based knowledge about their bodies, health, and sexuality. This episode covers a wide array of topics, including childbirth, menstruation, sexual education, common gynecological disorders, as well as menopause and aging. It highlights the urgent need to address persistent misconceptions and inequalities, advocating for a more patient-centric healthcare system.

Join Dr. Cornelius Maas, a former professional handball player who is now a partner at SHS Capital, a private investment firm specializing in medical technology and life sciences in the GSA region. Explore the unique challenges and groundbreaking trends poised to transform the industry and learn about the crucial systemic changes needed in Germany's healthcare system to ignite innovation and retain talent. Tune in for a compelling discussion on the future of healthcare and the pivotal role of private equity in driving progress.

In this Strategy& Insider podcast episode with Ambra Zhang, Co-founder and CEO of Juniper, we explore the groundbreaking approach her UK-based startup is taking in the realm of reproductive health insurance. Discover how Juniper is addressing significant health challenges, like endometriosis and prostate cancer, by destigmatizing discussions and implementing innovative insurance solutions.

In this episode, Clemens Utschig-Utschig, CTO at Boehringer Ingelheim, guides us through the digital and technological transformation of a 140-year-old family-owned pharmaceutical company. Explore how he utilizes data and technology to revolutionize drug development and personalized medicine, first and foremost quantum computing. Gain insights into strategic partnerships with BigTech and delve into a number of further leapfrog technologies in healthcare.